Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antibiotics in the prevention of heart attacks.

Literature DB >> 15680439

Antibiotics in the prevention of heart attacks.

John Danesh¹.

Abstract

Mesh：

Substances：
Anti-Bacterial Agents

Year: 2005 PMID： 15680439 DOI： 10.1016/S0140-6736(05)17842-8

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Paraoxonase-2 modulates stress response of endothelial cells to oxidized phospholipids and a bacterial quorum-sensing molecule.

Authors: Juyong Brian Kim; Yu-Rong Xia; Casey E Romanoski; Sangderk Lee; YongHong Meng; Yi-Shou Shi; Noam Bourquard; Ke Wei Gong; Zachary Port; Victor Grijalva; Srinivasa T Reddy; Judith A Berliner; Aldons J Lusis; Diana M Shih
Journal: Arterioscler Thromb Vasc Biol Date: 2011-11 Impact factor: 8.311

2. The failure of antibiotics to prevent heart attacks.

Authors: David Taylor-Robinson; Jens Boman
Journal: BMJ Date: 2005-08-13

3. Correlation of drug utilisation and morbidity at the municipality level. High use of antibiotics associated with low use of antihypertensives.

Authors: J Lars G Nilsson; Gunnar Lindberg; Hans Johansson; Arne Melander
Journal: Eur J Clin Pharmacol Date: 2006-07-06 Impact factor: 2.953

Review 4. Targeting inflammation: impact on atherothrombosis.

Authors: Maria Giulia Marini; Chiara Sonnino; Marco Previtero; Luigi M Biasucci
Journal: J Cardiovasc Transl Res Date: 2013-12-11 Impact factor: 4.132

5. Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial.

Authors: Christian M Jespersen; Bodil Als-Nielsen; Morten Damgaard; Jørgen Fischer Hansen; Stig Hansen; Olav H Helø; Per Hildebrandt; Jørgen Hilden; Gorm B Jensen; Jens Kastrup; Hans Jørn Kolmos; Erik Kjøller; Inga Lind; Henrik Nielsen; Lars Petersen; Christian Gluud
Journal: BMJ Date: 2005-12-08

6. Chronic Chlamydia pneumoniae infection may promote coronary artery disease in humans through enhancing secretion of interleukin-4.

Authors: R Clancy; Z Ren; G Pang; P Fletcher; C D'Este
Journal: Clin Exp Immunol Date: 2006-11 Impact factor: 4.330

Antibiotics in the prevention of heart attacks.

1. Paraoxonase-2 modulates stress response of endothelial cells to oxidized phospholipids and a bacterial quorum-sensing molecule.

2. The failure of antibiotics to prevent heart attacks.

3. Correlation of drug utilisation and morbidity at the municipality level. High use of antibiotics associated with low use of antihypertensives.

Review 4. Targeting inflammation: impact on atherothrombosis.

5. Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial.

6. Chronic Chlamydia pneumoniae infection may promote coronary artery disease in humans through enhancing secretion of interleukin-4.

Review 7. Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics.

8. A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseases.

9. Lack of association between Chlamydia Pneumoniae serology and endothelial dysfunction of coronary arteries.

Review 10. Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials.